HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiogenic activity of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT).

Abstract
The AG73 peptide (RKRLQVQLSIRT, mouse laminin alpha 1 chain 2719-2730) promotes cell adhesion and tumor metastasis, and interacts with transmembrane syndecan proteoglycans. Here, we demonstrate AG73 peptide angiogenic activity using in vitro, ex vivo, and in vivo models. AG73 induced murine endothelial cell (SVEC4-10) tube formation on Cultrex Basement Membrane Extract (Cultrex BME) and stimulated sprouting of aortic rings. None of the homologous sequences from the laminin alpha2, alpha3, alpha4, or alpha5 chains was as active as AG73 in promoting sprouting formation. AG73 also mediated angiogenesis in the chick chorioallantonic membrane (CAM) assay. Using subcutaneously injected Cultrex BME supplemented with AG73, we observed a large angiogenic response. Furthermore, AG73-conjugated to a chitosan membrane promoted a strong angiogenic response in the CAM assay. These results indicate that the AG73 peptide is a potent syndecan-binding angiogenesis stimulator and may be useful for therapeutic application to treat ischemic injuries.
AuthorsMayumi Mochizuki, Deborah Philp, Kentaro Hozumi, Nobuharu Suzuki, Yoshihiko Yamada, Hynda K Kleinman, Motoyoshi Nomizu
JournalArchives of biochemistry and biophysics (Arch Biochem Biophys) Vol. 459 Issue 2 Pg. 249-55 (Mar 15 2007) ISSN: 0003-9861 [Print] United States
PMID17286955 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AG 73
  • Angiogenic Proteins
  • Laminin
  • Peptide Fragments
  • Syndecans
Topics
  • Angiogenic Proteins (administration & dosage)
  • Animals
  • Cell Line
  • Chickens
  • Endothelial Cells (drug effects, physiology)
  • Laminin (administration & dosage)
  • Mice
  • Neovascularization, Physiologic (drug effects, physiology)
  • Peptide Fragments (administration & dosage)
  • Syndecans (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: